EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 200 mg/245 mg, comprimé pelliculé — 30 plaquette(s) OPA : polyamide orienté aluminium PVC de 1 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930093863 -
CIP7
3009386 -
CIS
62966914
What the source publishes
- Holder
- TEVA SANTE
- Active ingredients
- TÉNOFOVIR DISOPROXIL, EMTRICITABINE, PHOSPHATE DE TÉNOFOVIR DISOPROXIL
- Form
- comprimé pelliculé
- Package
- 30 plaquette(s) OPA : polyamide orienté aluminium PVC de 1 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2017-06-06
- Prescription
- Prescription or restricted
Names this record is found by
- EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 200 mg/245 mg, comprimé pelliculé — 30 plaquette(s) OPA : polyamide orienté aluminium PVC de 1 comprimé(s)
- EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 200 mg/245 mg, comprimé pelliculé
- TÉNOFOVIR DISOPROXIL
- EMTRICITABINE
- PHOSPHATE DE TÉNOFOVIR DISOPROXIL
Complete source data
{
"cis": "62966914",
"cip7": "3009386",
"form": "comprimé pelliculé",
"name": "EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 200 mg/245 mg, comprimé pelliculé — 30 plaquette(s) OPA : polyamide orienté aluminium PVC de 1 comprimé(s)",
"cip13": "3400930093863",
"holder": "TEVA SANTE",
"routes": [
"orale"
],
"holders": [
"TEVA SANTE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "152.48",
"authorisedOn": "2017-06-06",
"compositions": [
{
"name": "TÉNOFOVIR DISOPROXIL",
"nature": "FT",
"strength": "245 mg",
"linkageNumber": "2",
"substanceCode": "29337",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "EMTRICITABINE",
"nature": "SA",
"strength": "200 mg",
"linkageNumber": "1",
"substanceCode": "60459",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "PHOSPHATE DE TÉNOFOVIR DISOPROXIL",
"nature": "SA",
"strength": "291,22 mg",
"linkageNumber": "2",
"substanceCode": "80755",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "151.46",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 200 mg/245 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "30 plaquette(s) OPA : polyamide orienté aluminium PVC de 1 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2017-09-12",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"TÉNOFOVIR DISOPROXIL",
"EMTRICITABINE",
"PHOSPHATE DE TÉNOFOVIR DISOPROXIL"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930093863"